Mobilicom and ASP Isotopes Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / September 13, 2024 / RedChip Companies will air interviews with Mobilicom Ltd. (NASDAQ:MOB) and ASP Isotopes Inc. (NASDAQ:ASPI) on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this Saturday, September 14, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Access the interviews in their entirety at:

• Mobilicom: https://www.redchip.com/assets/access/mob_access

• ASP Isotopes: https://www.redchip.com/assets/access/aspi_access

Oren Elkayam, Founder and CEO of Mobilicom, appears on the RedChip Small Stocks, Big Money show on Bloomberg TV to provide a corporate update. Mobilicom presents a strong investment opportunity with its comprehensive and proprietary technology suite. The company's products, including SkyHopper Datalinks, Ground Control Systems, Mobile Mesh Networking, the ICE Cybersecurity Suite, and CONTROLiT cloud management, form the core 'brain' of drones, providing control, guidance, and cybersecurity. With a gross margin of 56% in the first half of 2024 primarily based on hardware sales, the company expects its revenues to be increasingly driven by Software-as-a-Service (SaaS) sales and recurring cybersecurity revenues from 2024 onwards. Revenues increased 232% year-over-year to $1.8 million in the first half of 2024, driven by initial production scale orders from U.S. and Israeli Tier-1 customers.

Paul Mann, CEO of ASP Isotopes, appears on the RedChip Small Stocks Big Money show on Bloomberg TV to provide a corporate update. ASP Isotopes harnesses two decades of research and development to produce a broad range of isotopes, serving the expanding needs of nuclear medicine and green nuclear energy sectors. The Company's cutting-edge technology positions it to meet critical global demands heightened by recent geopolitical dynamics. Financially, the Company is well positioned with a robust balance sheet, highlighted by no long-term debt and significant cash reserves. ASP Isotopes is poised for substantial revenue growth, with expectations of impactful revenue starting in 2024 as it ramps up commercial production. H.C. Wainwright maintains a buy rating on ASP Isotopes with a price target of $4.50 based on the Company's advanced de-risking measures and promising revenue prospects. This robust outlook, combined with strategic expansions and innovative operational strategies, underscores ASP Isotopes' strong potential for sustained growth and value creation for its shareholders.